Clinical Trial Update: POLARx Post Approval Study (POLARx PAS) [NA]

View source ↗

Summary

POLARx Post Approval Study (POLARx PAS) is a post-approval trial for the POLARx device in treating paroxysmal atrial fibrillation, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• POLARx

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: RECRUITING